摘要
随着分子营养学的飞速发展,利用特殊的营养素来实现合理化、个体化的临床肠内营养(EN)支持尤为迫切。我们综合国内外EN制剂中糖类的应用和海洋生物多糖综合利用现状,在传统陆源植物多糖膳食纤维型EN制剂研究的基础上,探讨分析海洋生物多糖在免疫增强型、癌症病人和糖尿病病人等EN制剂中的应用,提出了以海洋生物多糖为新的营养基质,开发各种疾病导向型EN制剂,为临床提供个体化的营养支持。
With the rapid development of molecular nutrition, the urgent demand of rationalizing and individual clinical enternal nutrition support was realized. The enteral nutrition was added with special nutrition substrate. The application of carbohydrate in enteral nutrition and the status of comprehensive use of polysaccharides were summarized in this article. Based on the study of traditional fiber in enteral nutrition(EN) , the application of marine polysaccharides on the diseases oriented EN was analyzed and discussed. So, new nutrition substrate from marine polysaccharides is proposed for exploitation of various diseases oriented EN. Therefore, the individual nutrition support becomes possible.
出处
《肠外与肠内营养》
CAS
北大核心
2010年第2期109-112,117,共5页
Parenteral & Enteral Nutrition
基金
中国科学院海洋生物资源可持续利用重点实验室(LMB)、广东省海洋药物重点实验室(LMM)和广东省应用生物学重点实验室(LAMB)联合开放课题资助项目
国家科技支撑项目(2008BAD94B08)
国家“863”计划资助项目(2007AA09602)
中国科学院知识创新工程重要方向创新项目(KZCX2-YW-209)
粤港关键领域重点突破项目(2007498611)